Snowball logo
logo
BTX

Lineage Cell Therapeutics Inc

BTX β€’ TA
β‚ͺ3.25β‚ͺ0.00Β  (0%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20142015201620172018TTM
Revenue
Total revenue
20.437.0365.9233.4584.9883.447
COGS
3.2601151.1070.3580.1680.3020.262
Gross Profit
17.175.9295.5653.294.6863.185
Operating Expenses & Income
Operating Income
(197.4)(65.81)(58.97)(40.66)(40.99)(39.75)
Total Operating Expenses
217.872.8464.8944.1145.9843.2
R&D Expenses
146.242.636.1124.0220.9518.86
Selling General & Admin Expenses
68.3829.1328.4319.9224.7324.08
Earnings from Continuing Operations
Interest Expense
-----(0.378)
Interest Income
------
Income Tax Expense
(28.64)(4.516)--(0.346)(5.978)
Net Income
Net Income
(141.8)(46.99)33.57(19.98)(45.99)31.05
Supplemental
EBIT
(197.4)(65.81)(58.97)(40.66)(40.99)(39.75)
EBITDA
------
In millions of ILS, except % and values per 1 share